3.46
+0(+0.00%)
Currency In USD
| Previous Close | 3.46 |
| Open | 3.5 |
| Day High | 3.5 |
| Day Low | 3.42 |
| 52-Week High | 13.5 |
| 52-Week Low | 2.36 |
| Volume | 5,503 |
| Average Volume | 14,249 |
| Market Cap | 3.74M |
| PE | -0.45 |
| EPS | -7.61 |
| Moving Average 50 Days | 3.15 |
| Moving Average 200 Days | 3.39 |
| Change | 0 |
If you invested $1000 in Heart Test Laboratories, Inc. (HSCS) since IPO date, it would be worth $14.3 as of May 09, 2025 at a share price of $3.46. Whereas If you bought $1000 worth of Heart Test Laboratories, Inc. (HSCS) shares 2 years ago, it would be worth $40.67 as of May 09, 2025 at a share price of $3.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
GlobeNewswire Inc.
Yesterday at 1:00 PM GMT
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
GlobeNewswire Inc.
May 07, 2025 1:00 PM GMT
Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
GlobeNewswire Inc.
May 01, 2025 1:00 PM GMT
Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives throug